Effect of nonpharmacologic therapies on depressive symptoms in patients with chronic fatigue syndrome: a network meta-analysis.
Jiang, Baiyi, Cao, Mengru, Xia, Xue et al. · Frontiers in psychiatry · 2025 · DOI
Quick Summary
This study looked at 47 different research trials involving over 4,000 people with ME/CFS to see which non-medication treatments might help reduce depression and low mood. The researchers found that dietary changes appeared most helpful, followed by traditional Chinese medicine approaches like moxibustion (heat therapy) and acupuncture. However, more high-quality research is needed to confirm these findings.
Why It Matters
Depression significantly worsens the overall disease burden in ME/CFS patients, yet treatment options are limited. This analysis systematically evaluates non-pharmacological alternatives that may be safer and more tolerable than medications, potentially offering clinicians and patients evidence-based options for managing comorbid depressive symptoms.
Observed Findings
Diet therapy showed the largest effect size for reducing depressive symptoms (SMD = -5.64)
Combined acupuncture plus moxibustion plus acupoint embedding interventions showed effect size of SMD = -3.16
Acupuncture plus moxibustion combination had effect size of SMD = -2.53
47 RCTs with 4,028 total participants met inclusion criteria
Inferred Conclusions
Diet therapy is the most effective non-pharmacological intervention for depressive symptoms in CFS patients
Traditional Chinese medicine approaches (moxibustion and acupuncture) represent promising adjunctive strategies
Non-pharmacological interventions merit further investigation as potential depression management tools in CFS
Carefully designed future RCTs are essential to confirm these preliminary findings
Remaining Questions
What specific dietary modifications are most effective, and what are the mechanisms underlying diet's impact on mood in ME/CFS?
How do these interventions compare to standard depression treatments or to each other in head-to-head trials?
What This Study Does Not Prove
This meta-analysis does not establish causal mechanisms for how these interventions reduce depression in ME/CFS, nor does it prove efficacy in any single individual patient. The wide confidence intervals and reliance on heterogeneous studies from multiple countries with varying methodological quality mean these findings are suggestive rather than definitive, and results may not apply uniformly across different ME/CFS populations.